Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key

Stroke. 2003 May;34(5):1334-5. doi: 10.1161/01.STR.0000069267.19971.7D. Epub 2003 Apr 17.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / classification
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / pharmacology
  • Calcium Channel Blockers / therapeutic use
  • Diuretics / administration & dosage
  • Diuretics / pharmacology
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Indapamide / administration & dosage
  • Indapamide / therapeutic use
  • Ischemic Attack, Transient / prevention & control
  • Meta-Analysis as Topic
  • Myocardial Infarction / prevention & control
  • Perindopril / administration & dosage
  • Perindopril / therapeutic use
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Stroke / etiology
  • Stroke / prevention & control*
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics
  • Indapamide
  • Perindopril